Production (Stage)
Sensei Biotherapeutics, Inc.
SNSE
$0.295
-$0.014-4.53%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 34.33M | 41.34M | 47.00M | 52.29M | 58.08M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 911.00K | 474.00K | 1.02M | 1.51M | 1.88M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 440.00K | 120.00K | 81.00K | 142.00K | 269.00K |
| Total Current Assets | 35.68M | 41.93M | 48.10M | 53.94M | 60.23M |
|
|
|||||
| Total Current Assets | 35.68M | 41.93M | 48.10M | 53.94M | 60.23M |
| Net Property, Plant & Equipment | 2.57M | 3.38M | 5.07M | 5.77M | 6.38M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 24.00K | 48.00K | 87.00K | 87.00K | 86.00K |
| Total Assets | 38.27M | 45.36M | 53.25M | 59.80M | 66.70M |
|
|
|||||
| Total Accounts Payable | 361.00K | 244.00K | 1.68M | 1.65M | 2.00M |
| Total Accrued Expenses | 2.63M | 2.73M | 1.33M | 848.00K | 514.00K |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 2.15M | 2.32M | 2.43M | 2.46M | 2.48M |
| Total Finance Division Other Current Liabilities | 88.00K | 157.00K | -- | -- | -- |
| Total Other Current Liabilities | 88.00K | 157.00K | -- | -- | -- |
| Total Current Liabilities | 5.23M | 5.45M | 5.44M | 4.95M | 4.99M |
|
|
|||||
| Total Current Liabilities | 5.23M | 5.45M | 5.44M | 4.95M | 4.99M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 1.06M | 1.53M | 2.03M | 2.59M | 3.16M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | 67.00K | 68.00K |
| Total Liabilities | 6.29M | 6.98M | 7.48M | 7.61M | 8.22M |
|
|
|||||
| Common Stock & APIC | 300.91M | 300.45M | 300.05M | 299.31M | 298.50M |
| Retained Earnings | -268.92M | -262.05M | -254.28M | -247.03M | -239.89M |
| Treasury Stock & Other | -6.00K | -13.00K | 14.00K | -93.00K | -137.00K |
| Total Common Equity | 31.99M | 38.39M | 45.78M | 52.19M | 58.47M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 31.99M | 38.39M | 45.78M | 52.19M | 58.47M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 31.99M | 38.39M | 45.78M | 52.19M | 58.47M |
|
|
|||||